Results 91 to 100 of about 21,169 (256)

Metastatic prostate cancer recurrence within a percutaneous computed tomography guided needle biopsy tract: A rare case report

UroPrecision, EarlyView.
Abstract Background Metastatic prostate cancer tumor seeding within a percutaneous biopsy tract is rare. While reports of tumor seeding following perineal and transrectal prostate biopsies exist, no cases of prostate cancer tumor seeding along a metastatic percutaneous bone biopsy tract detected by prostate specific membrane antigen (PSMA) positron ...
Thomas Neerhut, Thomas McMaster, Abigail Attwell‐Heap, Michael Kreltszheim   +3 more
wiley   +1 more source

Automated radiosynthesis of Al[18F]PSMA-11 for large scale routine use. [PDF]

, 2018
Objectives: We report a reproducible automated radiosynthesis for large scale batch production of clinical grade Al[F-18]PSMA-11. Methods: A SynthraFCHOL module was optimized to synthesize Al[F-18]PSMA-11 by Al[F-18]-chelation.
Brans, Boudewijn, Courtyn, Jan, De Man, Kathia, De Vos, Filip, Kersemans, Ken, Moerman, Lieselotte, Piron, Sarah, Van Royen, Tessa   +7 more
core   +1 more source

Utility of SUVmax on Primary Staging 68Ga‐PSMA PET in Determining Metastatic Status of Prostate Cancer

Journal of Medical Imaging and Radiation Oncology, EarlyView.
ABSTRACT Introduction 68Ga prostate‐specific membrane antigen (PSMA) has been shown to have prognostic value in detecting PSMA expressing metastasis from prostate cancer, but inevitably, there are cases in which suspected metastases demonstrate equivocal uptake.
Geoffrey Liu, Shane Lee, Kabir Ahmad
wiley   +1 more source

Unexpected discovery of hepatic cancer via 68Ga-PSMA PET/CT in the staging of prostate cancer

Current Problems in Cancer: Case Reports
PSMA PET/CT (prostate-specific membrane antigen-based positron emission tomography) measures the overexpression of PSMA with the highest sensitivity in prostate cancer, offering a feasible pathway for detecting primary tumors, metastasis, and recurrences.
Radu Alexa, Jennifer Kranz, Marco Hoffmann, Alexandra Barabasch, Sophie Leypold, Felix M. Mottaghy, Matthias Saar   +6 more
doaj   +1 more source

Synergistic cytotoxicity of irinotecan and cisplatin in dual-drug targeted polymeric nanoparticles [PDF]

, 2012
Aim: Two unexplored aspects for irinotecan and cisplatin (I&C) combination chemotherapy are: actively targeting both drugs to a specific diseased cell type, and delivering both drugs on the same vehicle to ensure their synchronized entry into the cell at
Bander, Neil H., Farokhzad, Omid C., Gadde, Suresh, Kantoff, Philip W., Karnik, Rohit, Langer, Robert, Lippard, Stephen J., Perea, Brian, Pridgen, Eric M, Pridgen, Eric M., Sweeney, Christopher, Valencia, Pedro M, Valencia, Pedro M.   +12 more
core   +1 more source

3D‐printed model for resection of positive surgical margins in robot‐assisted prostatectomy

BJU International, Volume 135, Issue 4, Page 657-667, April 2025.
Objectives To improve precision of secondary resection (SR) after positive surgical margin (PSM) detection by frozen section (FS) during nerve‐sparing (NS) robot‐assisted radical prostatectomy (RARP) by employing a personalised three‐dimensional (3D)‐printed prostate model derived from pelvic magnetic resonance imaging (MRI).
Christian Engesser, Philipp Brantner, Brigitta Gahl, Matthias Walter, Julian Gehweiler, Helge Seifert, Svetozar Subotic, Cyrill Rentsch, Christian Wetterauer, Lukas Bubendorf, Tatjana Vlajnic, Abolfazl Hosseini, Jan Ebbing   +12 more
wiley   +1 more source

Application Progress of 68Ga-PSMA PET/CT in Recurrent Prostate Cancer

Zhongliu Fangzhi Yanjiu, 2018
The morbidity of prostate cancer (PCa) is high. Early diagnosis of recurrence after primary treatment is very important for the prognosis. Prostate specific membrane antigen (PSMA) is a transmembrane glycoprotein, with high expression in PCa.
YANG Liping, LI Fuxing, LI Wengui
doaj   +1 more source

68Ga-PSMA-PET/CT for the evaluation of liver metastases in patients with prostate cancer [PDF]

, 2019
BACKGROUND: The purpose of this study was to evaluate the imaging properties of hepatic metastases in 68Ga-PSMA positron emission tomography (PET) in patients with prostate cancer (PC).
Brenner, Winfried, Damjanovic, Jonathan, Diederichs, Gerd, Janssen, Jan-Carlo, Makowski, Marcus R., Prasad, Vikas, Walter, Thula   +6 more
core   +1 more source

Metal-Based PSMA Radioligands

Molecules, 2017
Prostate cancer is one of the most common malignancies for which great progress has been made in identifying appropriate molecular targets that would enable efficient in vivo targeting for imaging and therapy.
Eleni Gourni, Gjermund Henriksen
doaj   +1 more source

Focal therapy using a novel cooled laser device for prostate cancer: early trial results

BJU International, EarlyView.
Objectives To determine the short‐term oncological results and safety of the ProFocal Laser Therapy for Prostate Tissue Ablation (PFLT‐PC) trial, the first phase II clinical trial of ProFocal® (Medlogical Innovations, Sydney, Australia), a novel, cooled laser focal therapy (cLFT) device for prostate cancer (PCa) treatment. Patients and Methods Men with
Jonathan Kam, Bishoy Hanna, Stuart Jackson, Stephen McCombie, George McClintock, Matthew J. Roberts, Jake Rahkala, Jeremy Teoh, Mohan Arianayagam, Bertram Canagasingham, Ahmed Saeed Goolam, Nicola Jeffery, Matthew Winter, Mohamed Khadra, Raymond Ko, Nicholas Mehan, Isaac Thangasamy, Celi Varol   +17 more
wiley   +1 more source